Tikehau Capital backs Medtrade

Through this £23m investment, Tikehau will provide strategic and operational support to accelerate the company's development and continue its global expansion.

Tikehau is investing via its minority growth equity fund, Tikehau Growth Equity II, which held a €150m close in 2018. The fund targets businesses with EBITDA in the range of €5-50m, providing investment tickets between €20-75m, and taking minority stakes.

Medtrade will be the fifth investment from the fund. Earlier this month it was announced that the GP backed France-based Addev Materials.

Company
Founded in 1999 and based in Crewe, Medtrade is a developer of medical device products with a successful track record in the advanced wound care and haemostat markets.

People
Tikehau Capital – Peter Cirenza (UK head).
Medtrade – Craig Hardy (co-founder).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• United Kingdom
• Tikehau Capital